Antibiotic Prescribing in Patients Presenting with COVID-19: A Closed-Loop Audit with a Targeted Educational Intervention in a South Australian Hospital

南澳大利亚一家医院针对新冠肺炎患者的抗生素处方情况:一项闭环审核及有针对性的教育干预措施

阅读:1

Abstract

Background/Objectives: Antimicrobial resistance is an escalating public health threat. Despite the low prevalence of community-acquired bacterial coinfection (CABC) in patients presenting with COVID-19, antibiotics are frequently prescribed. We evaluated antibiotic prescribing for suspected CABC in adults admitted with COVID-19 to a metropolitan referral hospital in South Australia and the impact of a targeted, locally developed educational intervention. Methods: We conducted a closed-loop retrospective audit of consecutive adult COVID-19 non-intensive care unit admissions to the General Medicine Unit over a six-month period (5 February-6 August 2024), totalling 126 episodes after exclusions. Antibiotic prescribing rates were compared before and after implementation of targeted education to admitting clinicians. This was delivered via guideline-focused presentations at unit meetings, emails and posters in key clinical areas detailing the consensus recommendation, and brief electronic reminder messages. Prescribing appropriateness was inferred from adherence to the consensus recommendation, which included predefined criteria relating to total leukocyte count, neutrophilia, and radiological findings. Statistical comparisons were performed using appropriate statistical tests for categorical and continuous variables. Results: Following the intervention, antibiotic prescribing decreased from 26% to 22% of admissions (p = 0.57), and prescribing among patients who did not meet the specified criteria fell from 16% to 6% (p = 0.30). The proportion of prescriptions meeting the consensus criteria increased from 62% to 80% (p = 0.43). Conclusions: Baseline antibiotic use was substantially lower than commonly published rates but still exceeded expected CABC prevalence. Targeted education and simple, locally adaptable guidance may support improved antimicrobial stewardship in COVID-19 admissions.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。